For the third year running, ControlCheck takes top marks in all product categories and receives a score of 90.9 out of 100
Arlington, VA–February, 8th 2022 –Bluesight, the leading automation vendor in Medication Intelligence solutions that brings cost savings, efficiency, and patient safety to hospitals, announced today that its ControlCheck product won Best in KLAS for Drug Diversion Monitoring in the 2022 Best in KLAS Report. Created by industry-leading healthcare technology analyst firm KLAS Research, the Best in KLAS title celebrates technology solutions that stand out from the competition in various categories.
“We are humbled to win this leading industry award for the third consecutive year. Solutions like ControlCheck are more important than ever,” said Kevin MacDonald, CEO and Co-Founder of Bluesight. “We are always looking for new ways to provide a seamless experience for our customers. They are at the center of everything we do and are essentially the driving force behind the advancements in the ControlCheck product. It is important to us that we are there for our customers when they need us and that our product continues to provide a platform to keep both their patients and staff safe.”
KLAS CEO Adam Gale provides some background on the Best in KLAS award. “Each year, thousands of healthcare professionals across the globe take the time to share their voice with KLAS. They know that sharing their perspective helps vendors to improve and helps their peers make better decisions. These conversations are a constant reminder to me of how necessary accurate, honest, and impartial reporting is in the healthcare industry. The Best in KLAS report and the awards it contains set the standard of excellence for software and services firms. Vendors who win the title of ‘Best in KLAS’ should celebrate and remember that providers now accept only the best from their products and services. The Best in KLAS award serves as a signal to provider and payer organizations that they should expect excellence from the winning vendors.”
For the report, 35 different ControlCheck users were interviewed about their experience with the product, a larger sample size than any other evaluated vendor. The feedback highlighted ControlCheck’s industry-leading features. Providers commented that ControlCheck performed hours and hours of manual audits and data analysis automatically, provided a framework for cohesive collaboration between nursing and pharmacy, and, most importantly, clearly identified providers with anomalous behavior patterns at a higher risk of diverting medications, without creating extraneous data points to sift through. Bluesight’s comprehensive product support and implementation services were also celebrated in provider feedback.
One director of pharmacy highlighted ControlCheck’s Investigation Portfolios feature, which creates a repeatable and robust cross-departmental investigation framework when suspected diversion arises.
“Our outcomes are really good just because of how blind we were before we had data from ControlCheck. We can see the data now. We can see a summary of the data. Before, we had data, but it would have taken a lifetime to get to it. The software is able to readily identify gaps. The system enables us not only to identify potential for diversion, but also to tighten up practices across various disciplines. For example, ControlCheck audits cases. If I have a discrepancy, I can quickly see that somebody either isn’t documenting as they should be or isn’t wasting as fast as they should be. For the first time, we can readily see how employees are deviating from policy and whether they are doing what we think they should be doing. We can see that very quickly every day.”
Additionally, another director of pharmacy highlighted the industry-leading support and feature collaboration ControlCheck users can expect from Bluesight.
“Our project manager has been highly available on numerous occasions for one-on-one training. Even if we had a key person that wasn’t available for training, our project manager would reschedule a one-on-one training just with that person to give them what they needed. We are all getting really good at doing virtual training. Bluesight also has a series of videos that the end user can access anytime, and I really like that fact because there is a lot to absorb. I personally went through the training, and when I didn’t remember something, I could bounce through the numerous videos and lea
hat thing all over again.”
The full 2022 Best in KLAS report is available here:https://klasresearch.com/report/2022-best-in-klas-awards-software-and-professional-services/2770.
The 2022 Best in KLAS segment for Drug Diversion Monitoring is available here: https://klasresearch.com/best-in-klas-ranking/drug-diversion-monitoring/2022/365
To learn more about Bluesight’s solutions, please visit www.kitcheck.com.
To learn more about KLAS, please visit http://www.klasresearch.com.